BRKR
What one share of Bruker holds
Laboratory Analytical Instruments
We are a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable our customers to explore life and materials at microscopic, molecular and cellular levels.
Bruker’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $23.02 |
|---|---|
| Profit | −$0.70 |
| Capex (buildings and equipment) | $0.63 |
| Free cash flow | $0.62 |
| Dividends | $0.15 |
| Cash and investments | $1.21 |
| Debt | $11.91 |
| Book value | $15.75 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $9.93 | $0.95 | $0.23 | $0.58 | $0.16 | $4.29 |
| 2017 | $11.10 | $0.49 | $0.27 | $0.70 | $0.16 | $4.65 |
| 2018 | $12.06 | $1.14 | $0.31 | $1.21 | $0.16 | $5.73 |
| 2019 | $13.23 | $1.26 | $0.47 | $0.90 | $0.16 | $5.88 |
| 2020 | $12.86 | $1.02 | $0.63 | $1.52 | $0.16 | $6.32 |
| 2021 | $15.81 | $1.81 | $0.60 | $1.25 | $0.16 | $7.10 |
| 2022 | $16.94 | $1.99 | $0.86 | $0.97 | $0.16 | $7.58 |
| 2023 | $20.14 | $2.90 | $0.73 | $1.65 | $0.20 | $9.49 |
| 2024 | $22.52 | $0.76 | $0.77 | $0.91 | $0.20 | $11.74 |
| 2025 | $22.64 | −$0.15 | $0.60 | $0.29 | — | $16.15 |